Email Updates

Search form

You are here

Multipurpose Prevention Technologies

HIV prevention and women’s reproductive health go hand in hand.

HIV prevention doesn’t happen in isolation. Even when people are at high risk for HIV, avoiding infection is but one factor in a complex set of decisions about their health and well-being. For women worldwide, those decisions include childbearing and reproductive and sexual health.

Multi-purpose prevention technologies are now in development to simultaneously prevent unintended pregnancy and protect against HIV and other sexually transmitted infections. By addressing multiple health concerns in convenient, easy-to-use formulations, these technologies might also help ensure high levels of product adherence. Multiple versions are entering early clinical trials now. Many important questions about efficacy, acceptability and adherence need to be addressed as this research proceeds.

What We're Reading

The case for MPT’s, as an opportunity to address STI’s and reproductive health needs, is spelled out in this letter published in the January issue of The Lancet. Author Matthew Quaife of the Department of Global Health and Development, London School for Hygiene & Tropical Medicine talks about a promising discrete choice experiment and more.

January 1, 2017
The Lancet

This analysis, published in the Guttmacher Policy Review, shows that research on multipurpose prevention technologies (MPTs) are vastly underfunded. MPTs could be especially important to women as they are designed to protect against multiple risks, like pregnancy and HIV. Despite the importance of new MPTs, research and development have been slowed due to insufficient funding.

September 15, 2015
Guttmacher Institute
Subscribe to RSS - Multipurpose Prevention Technologies